Author/Authors :
Joibi, Kimberly Fe Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Ibrahim, Salfarina Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Shafii, Nor Fadhilah Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Jusoh, Siti Asmaa Mat Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Mustaffa, Rapiaah Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Johan, Muhammad Farid Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia , Abdullah, Wan Zaidah Department of Hematology & Transfusion Medicine Unit - School of Medical Sciences - Universiti Sains Malaysia Health Campus, Kelantan, Malaysia
Abstract :
Biologically, Acute myeloid leukemia (AML) is highly heterogenous. AML with cup-like blast morphology
variant has been reported to have important role in risk group stratification and treatment implications. In
pediatric age group, this morphology and its clinical implication is rarely discussed. Although this morphology
variant is not stated in World Health Organization (WHO) classification of Tumours of Haematopoietic and
Lymphoid Tissues, it is associated with poor outcome from the association with other features. A 10- year old
girl diagnosed to have AML with this morphology variant is reported in this study. Her laboratory features were
hyperleucocytosis, high D-dimer, and blasts morphology of cup-like cells and few mimic the bilobed features of
acute promyelocytic leukemia (APML). Further investigation showed clinical and laboratory features similar to
what had been reported before in adults, including the presence of adverse marker of Fms-like tyrosine kinase 3
(FLT3) mutation. She was treated with chemotherapy, following which the bone marrow examination
documented marrow in remission. Unfortunately, she succumbed to the disease complication from sepsis and
marrow failure after few months of diagnosis. Haemato-morphologists might consider this unique
morphological recognition and correlate it with other findings, including molecular testing for proper clinical
evaluation. The blast feature and haematological findings could predict the clinical behaviour of this type of
AML and guide the patient management. This morphological variant serves an important role especially if
molecular testing is not available in some parts of the world or at the time of presentation when the result is still
pending.
Keywords :
Mutation , FLT3 , Blast , Acute myeloid leukemia